{"brief_title": "Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function", "brief_summary": "The purpose of this study is to evaluate the safety of injections of botulinum toxin Type A in patients with reduced lung function and focal upper limb poststroke spasticity", "condition": "Motor Neuron Disease", "intervention_type": "Drug", "intervention_name": "saline", "description": "Saline injection at Day 1, Week 12, Week 18", "arm_group_label": "3", "other_name": "BOTOX\u00ae", "criteria": "Inclusion Criteria: - Abnormal pulmonary function test results; - focal, upper limb spasticity, upper motor neuron syndrome Exclusion Criteria: - Previous exposure to botulinum toxin of any serotype", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00076687.xml"}